Main Street Compounding Pharmacy Recalls Compounded Methylprednisolone Vials
Main Street Compounding Pharmacy is recalling compounded preservative-free methylprednisolone vials due to reports of skin abscesses.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is Class II, and the source text reports specific adverse reactions (skin abscesses), which aligns with the rubric criteria for Severe severity involving injury reports.
Plain-English summary
Main Street Family Pharmacy, LLC is recalling compounded preservative-free methylprednisolone 80mg/ml 10 ml vials. The recall was initiated after the firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to the product.
The source text does not specify the exact distribution scope, lot numbers, or expiration dates for the affected units. Consumers who have received this product should contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Marcaine .2%/NS 450ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200
- Manufacturer
- Main Street Family Pharmacy, LLC
- Category
- Drug — Compounded Steroid
- Affected units
- 143
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- all codes distributed prior to and including 05/23/2013
Distribution
Part of a larger recall action
This product is one of 299 recalled by Main Street Family Pharmacy, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 299 products in this recall →Related recalls
Same manufacturer · Main Street Family Pharmacy, LLC
See all →- SevereMain Street Compounding Pharmacy Recalls Acetylcystein 10% Vials
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls Minoxidil 10% Due to Adverse Reactions
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls HCG 11000u w/B-12
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls Brompheniramine Due to Adverse Reactions
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls Methylcobalamin Due to Adverse Reaction Reports
FDA (Drugs) · 2013-12-11
Same hazard · infection
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- HighSurgipro Sutures Recalled for Potential Sterile Barrier Perforation
FDA (Devices) · 2026-08-19
- HighV-Loc 180 Absorbable Wound Closure Device Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 90 Absorbable Wound Closure Devices Recalled for Packaging Defects
FDA (Devices) · 2026-08-19